Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urothelial Carcinoma (UC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03317496
What this trial is testing

Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies

Who this might be right for
Non-small Cell Lung CancerUrothelial Cancer
Pfizer 67
Not applicableActive Not RecruitingNCT07155044
What this trial is testing

A Comparative Study of Neoadjuvant Chemotherapy Versus Upfront Radical Surgery for Upper Tract Urothelial Carcinoma

Who this might be right for
UTUCUC (Urothelial Cancer)
Changhai Hospital 120
Early research (Phase 1)Not Yet RecruitingNCT07807345
What this trial is testing

Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic

Who this might be right for
Head & Neck Squamous Cell CarcinomaNon-Small Cell Lung CancerEsophageal Cancer+5 more
Sutro Biopharma, Inc. 285
Early research (Phase 1)Looking for participantsNCT05176483
What this trial is testing

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+8 more
Exelixis 1,394
Not applicableLooking for participantsNCT07413523
What this trial is testing

Randomized Trial of stAndard of Care With or Without Metastases-directed Stereotactic Body Radiation Therapy in Patients Affected by Oligometastatic uRothelial carcinomA

Who this might be right for
Bladder CancerUrothelial Carcinoma (UC)Oligometastasis
Istituto Clinico Humanitas 44
Very early researchLooking for participantsNCT07439120
What this trial is testing

Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid Tumors

Who this might be right for
Urothelial Carcinoma (UC)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT06632951
What this trial is testing

Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC)

Who this might be right for
Urothelial Carcinoma
AbbVie 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631871
What this trial is testing

An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard Therapy

Who this might be right for
NeoplasmsSolid TumorsHER2 Positive Solid Tumor+7 more
Haihua Yuan 10
Not applicableLooking for participantsNCT07452432
What this trial is testing

Korean Prospective Upper Tract Urothelial Carcinoma Cohort

Who this might be right for
Urothelial Carcinoma (UC)
Samsung Medical Center 300
Early research (Phase 1)Study completedNCT01352962
What this trial is testing

Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors

Who this might be right for
Urethral NeoplasmsNeoplasms, UrethralCancer of the Urethra+1 more
National Cancer Institute (NCI) 18
Not applicableNot Yet RecruitingNCT07525349
What this trial is testing

Immune-Stromal Landscape in Muscle-Invasive Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder CarcinomaUrothelial Carcinoma (UC)Bladder Cancer+2 more
Assiut University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05651022
What this trial is testing

Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultHCC - Hepatocellular CarcinomaCRC (Colorectal Cancer)+5 more
Indaptus Therapeutics, Inc 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07643519
What this trial is testing

Neoadjuvant Enfortumab Vedotin Plus Pembrolizumab in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma (UC)
University of Florida 39
Testing effectiveness (Phase 2)Study completedNCT02872714
What this trial is testing

Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)

Who this might be right for
UC (Urothelial Cancer)
Incyte Corporation 263
Testing effectiveness (Phase 2)Looking for participantsNCT06682728
What this trial is testing

Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence

Who this might be right for
Urothelial CarcinomaMuscle-invasive Bladder Cancer
University of California, Irvine 23
Testing effectiveness (Phase 2)Study completedNCT01620970
What this trial is testing

PF-03446962 in Relapsed or Refractory Urothelial Cancer

Who this might be right for
Transitional Cell Carcinoma of Bladder
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 14
Testing effectiveness (Phase 2)Looking for participantsNCT04724018
What this trial is testing

Sacituzumab Govitecan Plus EV in Metastatic UC

Who this might be right for
Urothelial CancerMetastatic Urothelial CarcinomaMetastatic Urothelial Carcinoma of the Renal Pelvis and Ureter+1 more
Dana-Farber Cancer Institute 106
Not applicableStudy completedNCT06412848
What this trial is testing

JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study

Who this might be right for
Urothelial Carcinoma
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 360
Testing effectiveness (Phase 2)Ended earlyNCT03869190
What this trial is testing

Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC)

Who this might be right for
Urothelial CarcinomaBladder Cancer
Hoffmann-La Roche 272
Not applicableActive Not RecruitingNCT05779592
What this trial is testing

Evaluate Nivolumab in Japanese Participants With Muscle-invasive Urothelial Carcinoma

Who this might be right for
Muscle-invasive Urothelial Carcinoma
Bristol-Myers Squibb 400
Next Page